MARKET

IPA

IPA

Immunoprecise
NASDAQ
0.4489
-0.0086
-1.88%
After Hours: 0.4414 -0.0075 -1.67% 19:57 05/09 EDT
OPEN
0.4580
PREV CLOSE
0.4575
HIGH
0.4580
LOW
0.4365
VOLUME
316.72K
TURNOVER
--
52 WEEK HIGH
1.360
52 WEEK LOW
0.2700
MARKET CAP
20.54M
P/E (TTM)
-0.4152
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IPA last week (0428-0502)?
Weekly Report · 5d ago
Weekly Report: what happened at IPA last week (0421-0425)?
Weekly Report · 04/28 11:04
Weekly Report: what happened at IPA last week (0414-0418)?
Weekly Report · 04/21 11:04
Weekly Report: what happened at IPA last week (0407-0411)?
Weekly Report · 04/14 10:55
ImmunoPrecise Antibodies Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Dow Jones · 04/11 16:05
HC Wainwright & Co. Reiterates Buy on ImmunoPrecise Antibodies, Maintains $5 Price Target
Benzinga · 04/11 15:55
ImmunoPrecise Antibodies: Positioned for Growth with AI-Driven Drug Development Amid FDA Policy Shifts
TipRanks · 04/11 15:35
ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing
TipRanks · 04/11 13:09
More
About IPA
More
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Recently
Symbol
Price
%Change
    IPA
  • 0.4489
  • -1.88%

Webull offers Immunoprecise Antibodies Ltd stock information, including NASDAQ: IPA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPA stock methods without spending real money on the virtual paper trading platform.